An announcement from Nova Eye Medical ( (AU:EYE) ) is now available.
Nova Eye Medical Limited is hosting an Investor Webinar on 5 March 2025, where Managing Director Tom Spurling will discuss the company’s recent financial results and growth strategy. The company has reported strong sales growth, particularly in its Glaucoma Division, which is on track for profitability. The webinar aims to provide investors with insights into the company’s financial performance and future plans to expand its market presence.
More about Nova Eye Medical
Nova Eye Medical Limited is a medical technology company specializing in ophthalmic treatment technologies and devices. The company develops, manufactures, and sells products like the iTrack™ Advance, a minimally invasive glaucoma surgical device, and the Molteno3® glaucoma drainage device platform. These products are used globally by eye surgeons to manage glaucoma, with sales headquarters in Fremont, California, and manufacturing facilities in California and New Zealand.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $18.03M
Learn more about EYE stock on TipRanks’ Stock Analysis page.